DHR - התחייבויות לטווח ארוך של החברה Danaher Corporation
Danaher Corp. develops advanced biopharmaceutical technologies and laboratory diagnostics through large-scale R&D investments. The company's long-term debt metric clearly demonstrates the dynamics of its liabilities, where the parameter value equals 24.68. Stability is ensured by a business model based on the sale of consumables for high-cost equipment and a flawlessly optimized global supply chain that minimizes any logistical delays.
Danaher Corp (DHR) - פילוחי מדדים ודוחות פיננסיים
The scalability of the Danaher Corp. (DHR) business system requires significant investment, which is reflected in the trend of the issuer's long-term liabilities. This indicator captures the total volume of borrowed capital with a maturity of over one year to assess long-term solvency. The calculation is based on daily monitoring of debt liabilities, allowing for the tracking of risks associated with rising loan servicing costs amid increasing interest rates. A stable revenue stream from consumables offsets the pressure of the debt load.